
We're at an inflection point in artificial intelligence, presenting both tremendous potential opportunity and risk for people in developing countries. AI capabilities are improving on a timescale measured in months, while development systems often move on timescales measured in decades. Much of the technology needed for positive impact exists today, but few organizations exist to bridge research, deployment, and scaled implementation: we must act now to ensure AI's benefits reach people in poverty in low- and middle-income countries (LMICs).
Incubated at Evidence Action, we're rapidly scaling The AI Access Initiative, an organization focused on scaling AI-enabled 'big bets' to benefit tens or hundreds of millions of people in poverty in LMICs. We operate at the intersection of global development actors, top AI labs, and leading researchers to drive meaningful access to AI's benefits for the 3.5 billion people living in poverty globally. Given the scale of opportunity, we expect our portfolio to expand substantially, but to start, we're scaling two programs focused on AI in Agriculture and AI in Health across Africa and Asia.
We are led by former Evidence Action CEO Kanika Bahl, a founding member of Anthropic's Long-Term Benefit Trust, and advised by Nobel Laureate Michael Kremer; Dario Amodei, CEO of Anthropic; and Kent Walker, President, Global Affairs for Alphabet and Google. This work builds on Evidence Action's track record reaching 530M+ people with cost-effective, evidence-based programs across 9 countries in Africa and Asia, with a focus on last-mile delivery.
Our Agriculture and Health portfolios came out of a cross-sector analysis of near- and medium-term AI opportunities in LMICs. The Incubator is the engine that produces the next set of interventions ripe for scale. It is a new, 3-5 person research and incubation team with a single mandate: find the AI-enabled interventions that could plausibly clear a field-recognized cost-effectiveness bar at scale, test them and iterate on the delivery model, and hand the ones that survive to a program team as a fundable Big Bet.
The Incubator runs a four-stage pipeline, modeled on Evidence Action's Accelerator, which derisked programs like syphilis screening in pregnancy and in-line chlorination before they scaled: rapid screens (days), deep dives (weeks), on-the-ground pilots with light-touch monitoring, learning, and evaluation (MLE) (months), and a repeatable stack of tools, partners, and playbooks that gets easier to reuse each cycle, all aimed at producing new Big Bets. Most ideas will not make it all the way through; the team's value comes from making clear, fast, well-reasoned calls on which to set aside and which to advance.
Each member of the team owns interventions through the pipeline and also serves as the team's point person for one function, such as evidence, cost-effectiveness, program delivery, or AI product.
The Manager / Senior Manager, Incubation (Evidence) has two jobs. First, you will own a portfolio of potential AI-enabled interventions as they move through the Incubator, from first screen to pilot, and make the recommendation on what advances, what pauses, and what is set aside. Second, you will be the Incubator's point person for evidence and MLE: conducting and reviewing evidence reviews, working through the hardest evidence questions, and designing the MLE plans for our pilots.
Many of the interventions we assess build on programs with a strong evidence base, but the AI component often has little direct evidence behind it. A large part of this role is judging what evidence is good enough to act on at each stage, and designing pilots that generate the evidence that is missing.
This is a builder role in a start-up organization. The screening process, the evidence review approach, and the pilot MLE playbook do not exist yet. You will help create them, then use them, then improve them.
Own the case for (or against) potential Big Bets
Be the Incubator's point person for evidence
Design and oversee MLE for pilots
Help build the Incubator itself
The ideal candidate combines a track record of structured problem solving in fast, project-based environments with hands-on experience generating and interpreting evidence in LMICs. You can read a study critically, design a measurement plan that answers a decision-relevant question, and get to a clear recommendation when the evidence is thin.
You have also used AI to meaningfully enhance your work, and are energized by the prospect of translating AI capabilities into practical applications. The role is for someone who wants to own the question "what should 2AI do next, and how do we know," and who enjoys being accountable for the answer.
We are hiring at the Manager or Senior Manager level. Title and compensation will be set based on experience.
This role location is flexible anywhere in North America for fully remote candidates. This role requires the ability to travel internationally up to 25% of the time. We are unable to sponsor or take over sponsorship of a U.S. employment visa at this time. Applicants must be legally authorized to work in the U.S. for roles based in the U.S.
Evidence Action is an Equal Opportunity Employer with a commitment to diversity. All individuals, regardless of personal characteristics, are encouraged to apply.
The expected role range for this position is listed below. We consider multiple factors when determining the base salary for a role, including but not limited to: role scope, program budgets, internal equity, and a candidate's qualifications and/or prior experience.
Note: Pay and benefits will be commensurate with the role specifications, local statutory requirements, and the cost of labor in the markets where we operate.
The pay range for this role is: $100,000-135,000 USD.
While we are currently incubated at Evidence Action, 2AI plans to spin out on December 1, 2026 as an independent organization. New employees will be hired directly by 2AI. We will offer a comprehensive benefits package, including health, vision, and dental, retirement plans, generous and flexible leave options, as well as other employee perks.
Given this role will have a significant impact on our organization's early growth, we're focused on finding the right long-term fit while remaining as respectful of your time as possible. Our process is designed to explore both our shared culture and how we'd actually work together day-to-day.
Use of AI in our hiring process: We believe strongly in the importance of human judgment throughout hiring, from screening to final decisions. We use AI to support our team across the process, including application review, note-taking, scheduling, and project management. AI does not make hiring decisions or reject candidates. We do not use models that train on inputs or candidate data. By submitting your application, you acknowledge that we will use your information for recruitment purposes, including through these AI-supported tools, as described in our privacy notice.

Global impact starts with asking the right questions: How far can a dollar go to improve a person’s health? How can we learn if our strategies are working? How can we ensure that they will continue to work?
At Evidence Action, we leverage rigorous research and iterate constantly to scale low-cost health interventions at life’s most critical stages, including pregnancy, infancy, childhood, and adolescence. We always follow the data to ensure maximum value for every dollar and maximum impact for every individual.
Our programs have reached over 515 million people by pairing proven interventions with creative new implementation models tailored to local contexts. As we mark our 10-year anniversary, we reaffirm our commitment to expanding access, improving cost-effectiveness, and utilizing evidence to inform every decision.